GP
SNY icon

Girard Partners’s Sanofi SNY Stock Holding History

Girard Partners’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,464
Closed -$154K – 730
2018
Q3 		$154K Buy
+3,464
New +$148K 0.03% 274
2018
Q1 		– Sell
-6,724
Closed -$289K – 284
2017
Q4 		$289K Sell
6,724
-144
-2% -$6.64K 0.06% 222
2017
Q3 		$342K Buy
+6,868
New +$332K 0.07% 195

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Girard Partners's SNY Position: Q4 2018 in Review

Girard Partners sold out of Sanofi (SNY) in Q4 2018, closing a stake of 3,464 shares — an estimated $154K sold.

Girard Partners first reported a position in SNY in Q3 2017 and held it in 3 quarters. The position peaked at $342K in Q3 2017. 501 funds tracked by Wall St. Rank hold SNY as of Q4 2018.

  • Girard Partners reported no remaining Sanofi position as of Q4 2018 after selling out during the quarter.
  • Girard Partners sold 3,464 Sanofi shares in Q4 2018, an estimated $154K.
  • Girard Partners first reported a position in Sanofi in Q3 2017 and held it in 3 quarters.
  • Girard Partners's Sanofi position peaked at $342K in Q3 2017.
  • 501 funds tracked by Wall St. Rank held Sanofi as of Q4 2018.

Based on Girard Partners's 13F filing for Q4 2018, filed 11 Feb 2019.